Urinary candidiasis in a diabetes mellitus patient: case report

Dr Vu Van Ty1, Dr Bui Phuong Anh2, Dr Tra Anh Duy1, Dr Dang Dinh Hoan2
1 Urology Department - Binh Dan Hospital
2 Department of Diagnostic Imaging - Binh Dan Hospital

Main Article Content

Abstract

Background and purpose: To evaluate the diagnosis and treatment Candiduria in diabetes mellitus patient.
Case report: A Candiduria in a diabetes mellitus patient was diagnosed with 2D, color USG, MSCT & urin exams..Result was confirmed by surgery and anatomopathlology. The treatment was carried out in 7-2011 at Binh Dan hospital.
Result: 2 rounds of Fluconazole was indicated, clinical and para-clinical symtoms have been improved, but fungal cells still existing in urine.
Conclusion: Fungal infection of the urinary tract is a uncommon disease often occurs in patients with immunodeficiency,
our case from diabetes mellitus.. Treatment should be considered to use system and local antifungal drugs.

Article Details

References

1. Bartone FF, Hurwitz RS, Rojas El, et al (1998). The role of percutanous nephrostomy in the manegement of the obstructing candidiasis of the urinary tract in infants. J Urol, vol 140: 338-341.
2. Edwards JE (1991). Invasive Candida infections: Evolution of a fungal pathogen. N Engl J Med, vol 324:1060-1062.
3. Fan- Havard P, O’Donovan C, Smith SM, etal (1995). Oral fluconazole versus Amphtotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis, vol 31: 960-965.
4. Huang JJ, Tseng CC (2000). Emphysematous pyelonephritis: Clinico-radiological classifi-cation, management, prognosis, and pathogenesis. Arch Intern Med 2000;160:797-805.
5. Kauffman CA, Vazquez JA, Sobel JD (2000). A prospective Multicenter surveillance study of Funguria in hospitalized patients. Clin Infect Dis, vol 30: 14-18.
6. Kelly HA, MacCallum WG (1898). Pneumaturia. JAMA 1898; 31: 375
7. Manzano-Gayosso P, Henandez F, Zavala VM, Mendes TL, et al (2008). Candiduria in type 2 dianetes meltius patients and its clinical significance. Candida spp. Antifungal susceptibility. Rev Med Ints Mex Seguro Soc. Vol 46(6): 603-610.